Toggle navigation
Home
Search
Services
Blog
Contact
About
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
Wayne State University, Detroit, MI, United States
Search grants from Wayne State University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Using Clonal and Non-Clonal UV Signature Mutations to Predict Skin Cancer Risk
Synaptic adaptations underlying the incubation of cocaine craving
Immune Responses to Acetaldehyde Adducts
Celiac Disease in Osteoporosis
In Vitro Studies of Neural Control of Breathing
Recently added grants:
Targeting NSD1 in leukemia
DKK2 regulates NK activation and tumor immunity
Development of a Patient-Specific Surgical Planning Tool for Type I Laryngoplasty
Information and Dissemination in Support of Community Interventions
Hepatic stellate cell regulation of metastatic growth in the liver
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005022-001
Application #
6994809
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Related projects
NIH 2006
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2004
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2000
N01 CN
Phase II Clinial Trial of New Chemopreventive Agents - W
Kucuk, Omer / Wayne State University
$758,959
Comments
Be the first to comment on this grant